Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-24 @ 9:34 PM
NCT ID:
NCT06669832
Eligibility Criteria:
Inclusion Criteria:
* • Diagnosis of any solid malignancy, at any stage
* Completion of treatment (including surgery, radiotherapy, and any kind of cytotoxic systemic anticancer treatment \[hormonal and targeted treatments allowed\])
* Clinical, biochemical and radiological confirmation of controlled disease (no evidence of residual disease or not-progressive disease)
* Scheduled for either a therapeutic break (from cytotoxic systemic anticancer treatment), or having completed the planned multimodal treatment
* Scheduled for active surveillance plan within oncology service or discharged to surgical or GP care following completion of adjuvant treatment
* Male or female patients aged at least 18 years old
* WHO Performance Status 0-2
Exclusion Criteria:
* • Not in possession of a SIM card
* No internet access through Wi-Fi or unwilling to use mobile data allowance on a daily basis
* Unable to understand and follow the instructions autonomously
* Uncontrolled severe comorbidities (I.e., cardiovascular, neurological, respiratory)
* Lack of capacity
* Unable to understand English
* Still undergoing systemic anticancer treatment (apart from bone-targeted agents, hormonal treatment against breast or prostate cancers or maintenance monoclonal antibody monotherapy)
* Poor general condition (PS\>2)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06669832
Study Brief:
Protocol Section:
NCT06669832